In Re: Ariad Pharmaceuticals

CONCLUDED

Hearing
02/22/10 – 02/22/10

Play button overlay
Play button overlay

Summary

Hearing on motion to dismiss.

"The Complaint principally asserts that (1) Director Defendants Dr. Berger and Mr. LaMarche violated their fiduciary duties by disagreeing with the majority of other directors (the "Resigning Directors" and Dr. Lavidas) over the appropriate course for the Company to take in regard to acquiring the minority interest in ARIAD Gene Therapeutics, Inc. ("AGTI" that it did not already own, (2) all of the Director Defendants breached their fiduciary duties by voting in favor of an administrative change that resulted in one of the Resigning Directors no longer having the title of "vice chairman," and (3) Dr. Berger violated his duties by allegedly terminating the former in-house general counsel"

View a free video clip from the case:
Jack Sylvia argues on behalf of the nominal defendant, Ariad Pharma -- Clip 1

Sessions

Recording Disclaimer: This proceeding was recorded in full.

Suggest a Trial

Want to see a trial that you don't see in our list of upcoming trials?

Suggest a Case

CVN Essentials

The most important and informative moments of each trial

CVN Essentials

Video Library

Unlimited access to thousands of hours of past coverage of high stakes civil litigation

Video Library

  • Follow Us
  • Contact Us
  • 4901 Olde Towne Parkway
  • Suite 100
  • Marietta, GA 30068
  • 877-838-9067
  • 404-935-0321

Copyright 2023 Courtroom Connect.